MedTrace Logo

Safety and Efficacy Study of an Ophthalmic Solution in Patients With Age-Related Cataract

NCT00793091 · Status: UNKNOWN · Phase: PHASE2 · Type: INTERVENTIONAL · Enrollment: 80

Last updated 2008-11-27

No results posted yet for this study

Summary

The purpose of this study is to determine the safety and efficacy of C-KAD Ophthalmic Solution in improving visual acuity relative to placebo in patients with age-related cataract

Conditions

  • Cataract

Interventions

DRUG

C-KAD Ophthalmic Solution

4 drops applied daily for 120 days

DRUG

Placebo

4 drops applied daily for 120 days

Sponsors & Collaborators

  • Chakshu Research, Inc.

    lead INDUSTRY

Principal Investigators

  • Ira Wong, MD · Chakshu Research, Inc.

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
50 Years
Max Age
85 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2008-11-30
Primary Completion
2009-08-31
Completion
2009-09-30

Countries

  • United States

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT00793091 on ClinicalTrials.gov